WO2003059406A2 - Biodegradable auricular prosthetic device - Google Patents

Biodegradable auricular prosthetic device Download PDF

Info

Publication number
WO2003059406A2
WO2003059406A2 PCT/IT2002/000792 IT0200792W WO03059406A2 WO 2003059406 A2 WO2003059406 A2 WO 2003059406A2 IT 0200792 W IT0200792 W IT 0200792W WO 03059406 A2 WO03059406 A2 WO 03059406A2
Authority
WO
WIPO (PCT)
Prior art keywords
prosthetic device
tubular body
biodegradable
produced
opposed ends
Prior art date
Application number
PCT/IT2002/000792
Other languages
French (fr)
Other versions
WO2003059406A3 (en
Inventor
Riccardo D'eredita'
Original Assignee
D Eredita Riccardo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US10/501,641 priority Critical patent/US7163557B2/en
Application filed by D Eredita Riccardo filed Critical D Eredita Riccardo
Priority to EP02795422A priority patent/EP1465677B1/en
Priority to AU2002361120A priority patent/AU2002361120A1/en
Priority to DE60212881T priority patent/DE60212881T2/en
Publication of WO2003059406A2 publication Critical patent/WO2003059406A2/en
Publication of WO2003059406A3 publication Critical patent/WO2003059406A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F11/00—Methods or devices for treatment of the ears or hearing sense; Non-electric hearing aids; Methods or devices for enabling ear patients to achieve auditory perception through physiological senses other than hearing sense; Protective devices for the ears, carried on the body or in the hand
    • A61F11/20—Ear surgery
    • A61F11/202—Surgical middle-ear ventilation or drainage, e.g. permanent; Implants therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0004—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof bioabsorbable
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/14—Materials or treatment for tissue regeneration for ear reconstruction or ear implants, e.g. implantable hearing aids

Definitions

  • the subject of the present invention is a biodegradable auricular prosthetic device, particularly but not exclusively devised for the treatment of otitis media.
  • the treatment of otitis media provides for a tubular ventilation device to be surgically implanted in the tympanic membrane to balance a pressure difference established between the middle ear and the outer ear. At one time such implants had to be surgically removed at the end of the treatment.
  • biodegradable materials such as poiylactides
  • An example of such devices is described in US Patent 4.650.488.
  • the device described therein has a tapered body, of substantially frustoconical configuration, traversed axially by a hole and having a flanged end at the minor base.
  • the device, or at least the flanged portion thereof, is produced from a biodegradable material based on polymers of lactic acid.
  • Such a device has not hitherto been applied in the field inasmuch as it is potentially susceptible to exposing the patients in which it is implanted to numerous risks.
  • the poiylactides involve the risk of growth of granulation tissues consequent upon their imperfect absorption by the tissues. The formation of granulation tissues is particularly risky in auricular treatments.
  • Figure 1 is a view in longitudinal section of a prosthetic device according to the invention implanted in a tympanic membrane;
  • Figure 2 is a perspective view of the device of Figure 1;
  • Figures 3 to 5 are views in elevation of the device of the present invention produced in three further configurations.
  • the reference 1 indicates as a whole an auricular prosthetic device according to the invention, surgically implanted through a hole 2a made in the tympanic membrane 2 which sub-divides the ear into outer ear 3 and middle ear 4.
  • the epithelial tissues of the outer ear 3 and middle ear 4 are respectively of the squamous type (cutis) and the mucous type.
  • the device 1 comprises a tubular body having a cylindrical portion 10 of circular cross-section having two axialiy opposed ends with each of which there is associated, for example provided integrally, a respective flange 11, 12.
  • the flange 11, in use as an implant, is located on the middle ear side with respect to the tympanic membrane, while the flange 12 is on the outer ear side.
  • the tubular body is traversed by a through duct 14 which serves to ventilate the middle ear for the treatment of otitis (for example seromucosa).
  • At least the cylindrical portion 10 of the tubular body and the flange 11, but preferably the entire prosthetic device is produced from a reabsorbable biodegradable material selected from the group of polyphosphazenes and relative polymeric compounds. The use of such materials and the relative formulation are described in US Patent 6.077.916, the content of which is considered as forming an integral part of the present description.
  • the production of the entire device (or of both the flanges) from biodegradable material renders it reversible, preventing the possibility of errors of orientation thereof in the implant site.
  • the characteristics of biodegradability of the tubular body are variable along the axial extension thereof.
  • the speed of degradation of the cylindrical portion 10 it has proved preferable for the speed of degradation of the cylindrical portion 10 to be greater than the speed of degradation of the flanges 11, 12.
  • the degradation of the cylindrical portion occurs with regular reduction of its cross-section and the occlusion of the implant hole occurs with regular regrowth of the tissues on both sides of the tympanic membrane, avoiding different mechanical stresses on the tissues, as well as the risk of invagination and consequent cholesteatoma.
  • the variation of the degree of bioabsorption or biodegradability is obtained by means of irradiation (for example with gamma rays), since the areas subjected to greater irradiation generally assume a lesser molecular weight and an increase in the speed of degradation, or by producing the tubular body from different materials.
  • irradiation for example with gamma rays
  • the inner flange 11 falls into the middle ear and is reabsorbed without giving rise to the growth of granulation tissue, while the outer flange 12 and the relative portion of cylindrical body fall into the outer ear and are expelled or reabsorbed without consequence.
  • the possibility is provided of incorporating into the structure of the polymer drugs, growth factors, bacteriostatic substances and/or bactericides.
  • a first embodiment of the invention provides for the tubular body to be flanged at both the opposed ends in a bobbin configuration.
  • the flange 11 is arranged for the flange 11 to be provided with a pointed appendage 20, for perforating the tympanic membrane at the implant site, or for the tubular body to be flanged at only one end (Fig. 4 - in this case only the inner end 11) and further for said end flange to be oblique with respect to the axis of the cylindrical portion (Fig. 5).
  • the oblique flange 11 serves in such a case as an "arrowhead" to facilitate the perforation of the tympanic membrane at the implant site.
  • the invention thus solves the problem posed, also providing numerous advantages, among which are: the possibility of establishing a priori, beforehand, the duration of permanence of the implant based on the therapeutic requirements; the abolition of the need for removal with a consequent second surgical procedure (and the need for anaesthesia in children); the reduction of the risk of residual permanent tympanic perforation; the possibility of incorporating into the structure of the polymer drugs, growth factors, bacteriostatic substances and/or bactericides.

Abstract

A biodegradable auricular prosthetic device is described, particularly but not exclusively devised for the treatment of otitis media, comprising a tubular body having axially opposed ends and flanged at least at one of the opposed ends and at least a portion of which is produced from a material subject to biological degradation in the presence of organic liquids, wherein at least the portion made of material subject to biological degradation is produced from a polymeric material selected from the group of polyphosphazenes.

Description

Biodegradable auricular prosthetic device Technical field
The subject of the present invention is a biodegradable auricular prosthetic device, particularly but not exclusively devised for the treatment of otitis media.
Technological background
The treatment of otitis media provides for a tubular ventilation device to be surgically implanted in the tympanic membrane to balance a pressure difference established between the middle ear and the outer ear. At one time such implants had to be surgically removed at the end of the treatment. Nowadays there have been devised, but hitherto never produced on an industrial scale, devices produced from biodegradable materials, such as poiylactides, subject to biological degradation in the presence of organic liquids. An example of such devices (otherwise known as reabsorbable auricular ventilation tubes) is described in US Patent 4.650.488. The device described therein has a tapered body, of substantially frustoconical configuration, traversed axially by a hole and having a flanged end at the minor base. The device, or at least the flanged portion thereof, is produced from a biodegradable material based on polymers of lactic acid. Such a device has not hitherto been applied in the field inasmuch as it is potentially susceptible to exposing the patients in which it is implanted to numerous risks. Firstly, the poiylactides involve the risk of growth of granulation tissues consequent upon their imperfect absorption by the tissues. The formation of granulation tissues is particularly risky in auricular treatments. Moreover, both through the typical degradation of the material used and through the frustoconical configuration of the tapered body it involves the risk that the epithelial growth with which the hole for application of the prosthesis tends to close itself up again develops with invagination of the keratinized squamous epithelium, of the actual outer ear, along the conical portion and towards the middle ear, where mucous epithelium is present. There is in practice a risk of migration of the keratinized squamous epithelium towards the middle ear which is a possible cause of cholesteatoma. All the problems in question have hitherto led to delays in the marketing of devices of the aforesaid type. Moreover, up to now there have not been reabsorbable auricular ventilation tubes approved by the FDA (Federal Drug Administration) of the United States. Description of the invention
The problem underlying the present invention is therefore that of making available a prosthetic device structurally and functionally designed to remedy all the drawbacks mentioned with reference to the prior art cited. This problem is confronted and solved by the invention by means of a prosthetic device, such as an auricular ventilation tube, produced in accordance with the following claims. Brief description of the drawings
The characteristics and advantages of the invention will become clear from the description of a preferred exemplary embodiment thereof illustrated, by way of non-limiting example, with reference to the appended drawings, in which :
Figure 1 is a view in longitudinal section of a prosthetic device according to the invention implanted in a tympanic membrane;
Figure 2 is a perspective view of the device of Figure 1;
Figures 3 to 5 are views in elevation of the device of the present invention produced in three further configurations.
Preferred embodiment of the invention
In the drawings, the reference 1 indicates as a whole an auricular prosthetic device according to the invention, surgically implanted through a hole 2a made in the tympanic membrane 2 which sub-divides the ear into outer ear 3 and middle ear 4. The epithelial tissues of the outer ear 3 and middle ear 4 are respectively of the squamous type (cutis) and the mucous type. The device 1 comprises a tubular body having a cylindrical portion 10 of circular cross-section having two axialiy opposed ends with each of which there is associated, for example provided integrally, a respective flange 11, 12. The flange 11, in use as an implant, is located on the middle ear side with respect to the tympanic membrane, while the flange 12 is on the outer ear side. The tubular body is traversed by a through duct 14 which serves to ventilate the middle ear for the treatment of otitis (for example seromucosa). At least the cylindrical portion 10 of the tubular body and the flange 11, but preferably the entire prosthetic device, is produced from a reabsorbable biodegradable material selected from the group of polyphosphazenes and relative polymeric compounds. The use of such materials and the relative formulation are described in US Patent 6.077.916, the content of which is considered as forming an integral part of the present description. The production of the entire device (or of both the flanges) from biodegradable material renders it reversible, preventing the possibility of errors of orientation thereof in the implant site.
Preferably, the characteristics of biodegradability of the tubular body (understood as inclusive of the flanges) are variable along the axial extension thereof. For example, it has proved preferable for the speed of degradation of the cylindrical portion 10 to be greater than the speed of degradation of the flanges 11, 12. In this way the degradation of the cylindrical portion occurs with regular reduction of its cross-section and the occlusion of the implant hole occurs with regular regrowth of the tissues on both sides of the tympanic membrane, avoiding different mechanical stresses on the tissues, as well as the risk of invagination and consequent cholesteatoma. The variation of the degree of bioabsorption or biodegradability is obtained by means of irradiation (for example with gamma rays), since the areas subjected to greater irradiation generally assume a lesser molecular weight and an increase in the speed of degradation, or by producing the tubular body from different materials. Once the cylindrical portion 10 is severed, the inner flange 11 falls into the middle ear and is reabsorbed without giving rise to the growth of granulation tissue, while the outer flange 12 and the relative portion of cylindrical body fall into the outer ear and are expelled or reabsorbed without consequence. Moreover, the possibility is provided of incorporating into the structure of the polymer drugs, growth factors, bacteriostatic substances and/or bactericides. As has been emphasized, a first embodiment of the invention provides for the tubular body to be flanged at both the opposed ends in a bobbin configuration. Alternatively (Fig. 3) it is arranged for the flange 11 to be provided with a pointed appendage 20, for perforating the tympanic membrane at the implant site, or for the tubular body to be flanged at only one end (Fig. 4 - in this case only the inner end 11) and further for said end flange to be oblique with respect to the axis of the cylindrical portion (Fig. 5). The oblique flange 11 serves in such a case as an "arrowhead" to facilitate the perforation of the tympanic membrane at the implant site. The invention thus solves the problem posed, also providing numerous advantages, among which are: the possibility of establishing a priori, beforehand, the duration of permanence of the implant based on the therapeutic requirements; the abolition of the need for removal with a consequent second surgical procedure (and the need for anaesthesia in children); the reduction of the risk of residual permanent tympanic perforation; the possibility of incorporating into the structure of the polymer drugs, growth factors, bacteriostatic substances and/or bactericides.

Claims

C L A I M S 1. A biodegradable auricular prosthetic device, particularly but not exclusively devised for the treatment of otitis media, comprising a tubular body having axially opposed ends and flanged at least at one of said opposed ends and at least a portion of which is produced from a material subject to biological degradation in the presence of organic liquids, characterized in that at least said portion made of material subject to biological degradation is produced from a polymeric material selected from the group of polyphosphazenes. 2. A prosthetic device according to claim 1, wherein at least said portion made of material subject to biological degradation has variable biodegradability characteristics along the axial extension of said tubular body. 3. A prosthetic device according to claim 1 or 2, wherein said tubular body has a cylindrical configuration. 4. A prosthetic device according to claim 3, wherein said tubular body, in an intermediate portion thereof comprised between said ends, has a greater biodegradability with respect to the biodegradability of said flange(s). 5. A prosthetic device according to one or more of the preceding claims, wherein said body is flanged at both said opposed ends in a bobbin shape. 6. A prosthetic device according to one or more of the preceding claims, wherein there are incorporated into said polymeric material substances selected from drugs, growth factors, bacteriostatic substances and/or bactericides, singly or in admixture with one another.
PCT/IT2002/000792 2002-01-16 2002-12-16 Biodegradable auricular prosthetic device WO2003059406A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US10/501,641 US7163557B2 (en) 2002-01-16 2002-01-16 Biodegradable auricular prosthetic device
EP02795422A EP1465677B1 (en) 2002-01-16 2002-12-16 Biodegradable auricular prosthetic device
AU2002361120A AU2002361120A1 (en) 2002-01-16 2002-12-16 Biodegradable auricular prosthetic device
DE60212881T DE60212881T2 (en) 2002-01-16 2002-12-16 BIODEGRADABLE AURICULAR PROSTHESES

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITPD2002A000005 2002-01-16
IT2002PD000005A ITPD20020005A1 (en) 2002-01-16 2002-01-16 BIODEGRADABLE PROSTHETIC HEADSET DEVICE

Publications (2)

Publication Number Publication Date
WO2003059406A2 true WO2003059406A2 (en) 2003-07-24
WO2003059406A3 WO2003059406A3 (en) 2004-03-25

Family

ID=11452501

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IT2002/000792 WO2003059406A2 (en) 2002-01-16 2002-12-16 Biodegradable auricular prosthetic device

Country Status (7)

Country Link
US (1) US7163557B2 (en)
EP (1) EP1465677B1 (en)
AT (1) ATE331538T1 (en)
AU (1) AU2002361120A1 (en)
DE (1) DE60212881T2 (en)
IT (1) ITPD20020005A1 (en)
WO (1) WO2003059406A2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7833282B2 (en) * 2006-02-27 2010-11-16 Mandpe Aditi H Eustachian tube device and method
US10758421B2 (en) 2013-08-21 2020-09-01 Children's National Medical Center Dissolvable on-command implant
EP3827796A1 (en) * 2012-06-13 2021-06-02 Matheny Enterprises, LLC Biodegradable, active ingredient-eluting structural support

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090088844A1 (en) * 2007-07-03 2009-04-02 Keegan Mark E Drug-eluting stapes prosthesis
US20090036996A1 (en) * 2007-08-03 2009-02-05 Roeber Peter J Knit PTFE Articles and Mesh
US20090187197A1 (en) * 2007-08-03 2009-07-23 Roeber Peter J Knit PTFE Articles and Mesh
US8614189B2 (en) * 2008-09-24 2013-12-24 University Of Connecticut Carbon nanotube composite scaffolds for bone tissue engineering
US9326943B1 (en) 2009-06-23 2016-05-03 Sandra M. Skovlund Biodegradable prosthesis
EP2569004A4 (en) 2010-05-10 2016-01-20 Univ Connecticut Lactoferrin -based biomaterials for tissue regeneration and drug delivery
US9011363B2 (en) 2012-04-10 2015-04-21 Acclarent, Inc. Tympanic membrane pressure equalization tube
WO2013169374A1 (en) 2012-05-10 2013-11-14 The Trustees Of The Stevens Institute Of Technology Biphasic osteochondral scaffold for reconstruction of articular cartilage
CA2980504C (en) 2015-03-20 2024-01-30 Massachusetts Eye And Ear Infirmary Artificial tympanic membrane devices and uses
EP3512476A4 (en) * 2016-09-16 2019-10-09 Massachusetts Eye & Ear Infirmary Ear canal grafts
DE102018114274B3 (en) 2018-06-14 2019-08-22 Universität Rostock Apparatus for middle ear aeration and deaeration

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4650488A (en) * 1984-05-16 1987-03-17 Richards Medical Company Biodegradable prosthetic device

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2127903A (en) * 1936-05-05 1938-08-23 Davis & Geck Inc Tube for surgical purposes and method of preparing and using the same
US3620218A (en) * 1963-10-31 1971-11-16 American Cyanamid Co Cylindrical prosthetic devices of polyglycolic acid
DK0627911T3 (en) * 1992-02-28 2000-11-20 Univ Texas Photopolymerizable biodegradable hydrogels as tissue contact materials and controlled release carriers
FI954565A0 (en) * 1995-09-27 1995-09-27 Biocon Oy Biologically applied polymeric material to the implant and foil preparation
US6077916A (en) * 1997-06-04 2000-06-20 The Penn State Research Foundation Biodegradable mixtures of polyphoshazene and other polymers
US6333029B1 (en) * 1999-06-30 2001-12-25 Ethicon, Inc. Porous tissue scaffoldings for the repair of regeneration of tissue

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4650488A (en) * 1984-05-16 1987-03-17 Richards Medical Company Biodegradable prosthetic device

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE MEDLINE [Online] US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US; July 2002 (2002-07) D'EREDITÀ RICCARDO ET AL: "A new absorbable pressure-equalizing tube." Database accession no. NLM12161733 XP002245813 & OTOLARYNGOLOGY--HEAD AND NECK SURGERY: OFFICIAL JOURNAL OF AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY. UNITED STATES JUL 2002, vol. 127, no. 1, July 2002 (2002-07), pages 67-72, ISSN: 0194-5998 *
DE SCHEERDER VVAN K KRZYSZTOF L WILCZEK ET AL: "Biocompatibility of polymer-coated oversized metallic stents implanted in normal porcine coronary arteries." ATHEROSCLEROSIS, vol. 114, no. 1, 1995, pages 105-114, XP002245812 ISSN: 0021-9150 *
LANGONE F ET AL: "Peripheral nerve repair using a poly(organo)phosphazene tubular prosthesis" BIOMATERIALS, ELSEVIER SCIENCE PUBLISHERS BV., BARKING, GB, vol. 16, no. 5, 1995, pages 347-353, XP004033038 ISSN: 0142-9612 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7833282B2 (en) * 2006-02-27 2010-11-16 Mandpe Aditi H Eustachian tube device and method
EP3827796A1 (en) * 2012-06-13 2021-06-02 Matheny Enterprises, LLC Biodegradable, active ingredient-eluting structural support
US10758421B2 (en) 2013-08-21 2020-09-01 Children's National Medical Center Dissolvable on-command implant

Also Published As

Publication number Publication date
US20050075733A1 (en) 2005-04-07
EP1465677B1 (en) 2006-06-28
AU2002361120A8 (en) 2003-07-30
DE60212881D1 (en) 2006-08-10
AU2002361120A1 (en) 2003-07-30
EP1465677A2 (en) 2004-10-13
US7163557B2 (en) 2007-01-16
ITPD20020005A1 (en) 2003-07-16
DE60212881T2 (en) 2007-01-11
ATE331538T1 (en) 2006-07-15
WO2003059406A3 (en) 2004-03-25

Similar Documents

Publication Publication Date Title
EP1465677B1 (en) Biodegradable auricular prosthetic device
US20210378698A1 (en) Device and methods for treating paranasal sinus conditions
US8197552B2 (en) Eustachian tube device and method
KR101577602B1 (en) Self-retaining sutures with bi-directional retainers or uni-directional retainers
US20170296309A1 (en) Bioresorbable Inflatable Devices, Incision Tool And Methods For Tissue Expansion And Tissue Regeneration
US20080294255A1 (en) Sinus Tube
US20050008673A1 (en) Sustained release surgical device and method of making and using the same
CN106137482B (en) A kind of nasal sinus stent and transport system
CN106039547A (en) Expandable devices and methods therefor
KR101697533B1 (en) Devices for dilating a paranasal sinus opening and for treating sinusitis
KR20220108830A (en) Implantable scaffolds for treatment of sinusitis
EP1137379A1 (en) Bioerodable myringotomy tube
AU2012261629B2 (en) Eustachian Tube Device and Method
AU2021229505A1 (en) Cerebral dural venous sinus stent

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 10501641

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2002795422

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2002795422

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

WWG Wipo information: grant in national office

Ref document number: 2002795422

Country of ref document: EP